This Million Shows Growing Confidence in 10x Genomics
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Timing a rebalance for blue chip crypto holdings relies on predefined thresholds and market conditions. Use objective signals to keep allocation aligned with goals.
13,373 articlesA hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Gold is climbing as central banks snapping gold drives a new bid, with ETF buyers joining sovereign demand. This piec...
When headlines scream that wall street nervous, it pays to look back. A century of S&P 500 history shows how big drop...
Astera Labs has captured investor attention with a strong rally. This article dives into the reasons behind the move,...
An $18 million wager on a rental business with decades of dividend growth sounds ambitious. This article breaks down ...
Is Rivian a millionaire-maker stock or a high-risk punt? This guide dives into the catalysts, margins, and scenarios ...
June's trading floor is flashing mixed signals: a SpaceX-inspired rally taps telecom names, but EchoStar pulls back o...
A long-remembered jab about Chrome’s prospects resurfaces as the browser landscape continues to evolve. Here’s what i...
Intel has surged about 570% in the last year, turning a sleepy chipmaker into a headline stock. This guide breaks dow...
When americans cutting back spending becomes the backdrop, investors wonder where growth still hides. This article br...
A CFO selling a substantial stake can spark questions about a company’s short-term risk and long-term strategy. This ...
BlackRock just became first to hit a historic $15 trillion in assets under management. This milestone signals scale, ...